Artiva Biotherapeutics Inc. (ARTV) - Market Valuation

Graphic logo of Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics, Inc. (ARTV) attracts leading immunologists by developing off-the-shelf NK therapies, leveraging strict GMP standards and an option system. This price action chart, where the indicator stands at 0.19, confirms the development of this process. The business is based on partnerships with academic oncology centers. Additionally, Artiva Biotherapeutics, Inc. (ARTV) is implementing closed automated bioreactors to eliminate human error and contamination during the production of allogeneic drugs.

ARTV (Artiva Biotherapeutics) Market Value history from 07/20/2024 to 11/18/2026

Metric breakdowns and analytics for Artiva Biotherapeutics Inc. (ARTV)

Fundamental company valuation:Artiva Biotherapeutics ARTV
Product sample of Artiva Biotherapeutics

Market capitalization dynamics drive institutional investor interest in Artiva Biotherapeutics, Inc. (ARTV) shares. Calculating this metric via the total value of all shares smooths volatility, stripping the trend of random outliers. The company's current market value on GURU.Markets reflects the business's fundamental value. For Artiva Biotherapeutics, Inc. (ARTV), this indicator confirms the market valuation of NK-cell production automation in bioreactors. The steady growth of this metric signals the high reliability of the asset.

Competitors of Artiva Biotherapeutics, Inc. (ARTV)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|CVM: Market Capitalization|OS Therapies Inc - Market Value|RADX (radiopharmtheranostics.com) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group